Drug details

Abraxane (albumin-bound paclitaxel for injectable suspension)

type of Antineoplastics, Antimicrotubular

Abraxane (paclitaxel protein-bound particles for Injectable suspension) is a cancer (antineoplastic) medication used in the treatment of breast cancer.

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• temporary hair loss.
• indigestion,
• diarrhea,
• mouth sores,
• muscle or joint pain,
• numbness/tingling/burning of the hands or feet,
• weakness,
• infections,
• anemia, or

The following drugs are related to Abraxane, either as a replacement or used together:

• Fosamax (alendronate sodium)
• Fosamax Plus D (alendronate sodium and cholecalciferol)
• Aredia (pamidronate disodium)
• Aromasin (exemestane)
• Onureg (azacitidine tablets)
• Tabrecta (capmatinib tablets)
• Cytalux (pafolacianine injection)
• Elahere (mirvetuximab soravtansine-gynx injection)
• Ellence (epirubicin hydrochloride)
• Pharmorubicin (epirubicin)
• Exkivity (mobocertinib capsules)
• Fareston (toremifene)
• Faslodex (fulvestrant)
• Halotestin (fluoxymesterone)
• Gavreto (pralsetinib capsules)
• Zoladex 10.8 mg (goserelin acetate implant)
• Zoladex 3.6 (goserelin acetate implant)
• Sancuso (granisetron transdermal system)
• Herceptin (trastuzumab)
• Herzuma (trastuzumab-pkrb for injection)
• Ibrance (palbociclib capsules for oral administration)
• Ixempra (ixabepilone)
• Lumakras (sotorasib tablets)
• Zepzelca (lurbinectedin for injection)
• Nolvadex (tamoxifen citrate)
• Pemfexy (pemetrexed injection for intravenous use)
• Trodelvy (sacituzumab govitecan-hziy for injection, for iv use)